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Key Questions relating to left ventricular noncompaction cardiomyopathy - Is 
the Emperor still wearing any clothes? 
Abstract 
The evidence is increasing that left ventricular noncompaction cardiomyopathy, as it is 
currently defined, does not represent failure of compaction of pre-existing trabecular 
myocardium found during embryonic development so as to form the compact component 
of the ventricular walls. Nor is there evidence, of which we are aware, to favour the notion 
that the entity is a return to a phenotype as seen in cold-blooded animals. It is also known 
that, when seen in adults, the presence of excessive ventricular trabeculations does not 
portend a poor prognosis when ejection fraction is normal, with the risks of complications 
such as arrhythmia and stroke being rare in this setting. It is also the case that images of 
“noncompaction” as provided from children, or in autopsy studies, are quite different from 
the features observed clinically in the asymptomatic adults with excessive trabeculation. 
Our review suggests that the presence of an excessively trabeculated left ventricular wall is 
not, in itself, a clinical entity. It is equally possible that the excessive trabeculation is no 
more than a bystander in the presence of additional lesions, such as dilated 
cardiomyopathy, with the additional lesions being responsible for the reduced ejection 
fraction bringing a given patient to clinical attention. We, therefore, argue that the term 
“noncompaction cardiomyopathy” is misleading, as there is neither failure of compaction 
nor a cardiomyopathic process in most individuals that fulfil widely used diagnostic criteria. 
Introduction 
Although yet to be generally accepted, it is increasingly frequent to find the term 
“noncompaction cardiomyopathy” or “left ventricular noncompaction” used when excessive 
trabeculations are present in the left ventricle. As we will seek to establish in our review, 
there is no convincing evidence to show the finding of excessive trabeculation is 
representative of a discrete cardiomyopathy. We will, therefore, describe the condition 
simply as “noncompaction“, retaining use of inverted commas in the subsequent text. The 
condition is usually diagnosed by indexing the thickness of the trabeculated layer of the left 
ventricular wall to that of the solid, or compacted, component. Different groups, 
nonetheless, have recommended various diagnostic criteria for establishing the presence of 
the phenotype.1-7 When present, the condition has been linked to heart failure, malignant 
arrhythmias, and thromboembolic events. It is currently considered by some to be a distinct 
entity.8 The number of publications relating to the condition, furthermore, has risen sharply 
in recent years. Thus, its citation has risen from relative obscurity to more than 1500 
citations, with some 80 publications now emerging every year. This fact prompted Captur 
and colleagues to liken the alleged lesion to the 20th century phenomenon of excessive 
diagnosis of mitral valvar prolapse.9  These considerations raise several questions.  
In the first place, we wonder whether the diagnosis of “noncompaction” will diminish in 
comparable fashion to the current diagnostic incidence of individuals with symptomatic 
prolapse of the leaflets of the mitral valve? It is already evident that a substantial proportion 
of those individuals who fulfil widely used criteria for the condition are asymptomatic and 
have good prognosis, providing evidence to support the notion that excessive 
trabeculations, in themselves, do not provide clinically useful information.10 This then raises 
the second question. Is the common presumption justified, as the term implies, that the 
presence of the excessive layer of trabecular myocardium in the postnatal heart is itself 
associated with inappropriate formation of the compact components of the ventricular 
walls? We can rephrase this question to ask if there is any evidence to show that the 
trabeculations, which unequivocally make up the greater thickness of the ventricular walls 
in the developing embryo, subsequently coalesce to form the compact component of the 
wall? If this is not the case, the third question is whether the presence of excessive 
trabeculation is no more than one end of the normal variation in persistence of the initial 
ventricular trabeculations? If the latter is the case, the fourth question is what else is 
required to bring some of these individuals to the attention of cardiologists? In this regard, 
there are then further areas of uncertainty. Is there an anatomical difference between 
individuals with increased trabeculations who do, or do not, have a reduced ejection 
fraction or a poor clinical outcome? And is the condition different in children as opposed to 
adults, and in those with otherwise normal as opposed to congenitally malformed hearts? In 
this review, representing as we do a group of individuals with varied interests and expertise, 
we dissect the evidence underscoring these various questions. 
Trabeculations in the animal kingdom 
The formation of the trabecular layer of the ventricular walls has recently been reviewed in 
the Canadian Journal of Cardiology.11 All vertebrate animals, during their embryogenesis, 
exhibit a highly trabeculated ventricle.12 The trabeculations within the embryonic ventricle 
are thin, less than 50 micrometres in diameter, so that they are adequately supplied by 
diffusion from the luminal blood in which they are bathed. As there is no coronary 
circulation during the early stages of embryogenesis, greater ventricular mass can be 
accomplished by growth of the trabeculations.13 This highly trabeculated and avascular 
ventricular design is maintained into adulthood in most of the cold-blooded vertebrate 
animals.14, 15 In humans, in contrast, as is the case in warm-blooded vertebrate animals in 
general, the fetal period is characterized by a sustained growth of the compact wall, which 
makes up no more than the meagre outer shell of the embryonic ventricle.16-18 
During fetal development, the thickness of the compact component of the wall outgrows 
the extent of the trabeculations many-fold. It is a fact that some of the embryonic-like 
trabeculations will either coalesce, or compact, or re-initiate growth, so as to assume a 
phenotype like that of the compact wall, with this process seen most clearly in the 
development of the papillary muscles.19 Eventually, trabeculations resembling those of the 
embryo are found only in the fine network that constitutes the Purkinje myocardium of the 
ventricular conduction system14, 20 Because warm-blooded vertebrates have higher blood 
pressures than cold-blooded vertebrates,21 the developmental and evolutionary changes 
occurring during transformation from a trabeculated to compact wall could relate to force-
production. The highly trabeculated ventricles of some species, such as the tuna fish, 
varanid lizards, python snakes, and crocodiles, all generate systemic blood pressures in the 
range of mammals.21 The stroke work done per gram ventricular tissue, irrespective of it 
being trabeculated or compact, is not different between cold- and warm-blooded 
vertebrates.22 And, in the most comprehensive review of the cardiac anatomy of mammals, 
the degree of trabeculation did not show any obvious correlation to the performance of the 
animal.23 Instead, the changes that take place during the transformation of a largely 
trabeculated to a predominantly compact wall may enable faster filling and emptying of the 
ventricles. It may thus be related to the high heart rates found in mammals and birds.24 
When surveying the animal kingdom, therefore, we find no reason to believe that a 
trabeculated ventricle is at a mechanical disadvantage in terms of force-production. Indeed, 
we have established that the degree of trabeculation of the human heart does not predict 
ejection fraction.10, 12 In some individuals, nonetheless, the presence of excessive 
trabeculation is associated with reduced ejection fraction. It has yet to be established if 
there is a causal relationship between the two features.  
What is the experimental evidence supporting the notion of compaction of pre-existing 
trabeculations? 
Many of the current clinical descriptions relating to left ventricular “noncompaction”, as 
indeed was the case in one of our original essays on the topic, introduce their work by 
presuming that the initial trabeculations observed in the developing human heart coalesce 
to form the compact components of the ventricular walls. The review provided by Sedmera 
and associates, which included one of the current authors, is usually cited as the basis for 
this presumption.25 The review, however, was just that. It was based primarily on 
interpretations of previous studies, although backed up by scanning electron microscopic 
studies of developing hearts, mostly from chicks, but also including examples of developing 
human hearts. No direct evidence was provided to show that the compact layers of the 
ventricular walls were formed from the initial trabeculations. If we now re-examine the 
morphologic evidence available from serially sectioned developing human hearts, we can 
see that the compact component of the ventricular walls is already well-formed at Carnegie 
stages 15 or 16 in the presence of a thick layer of persisting trabecular myocardium (Figure 
1). Similar evidence is available from studies of developing murine hearts, with these 
developmental series showing that, although the papillary muscles of the mitral valve are 
unequivocally formed by compaction of pre-existing trabeculations, this is not necessarily 
the case for the compact component of the ventricular walls. Thus, lineage tracing of the 
embryonically formed trabeculations show that they contribute little, if anything, to the 
compact wall during the fetal period, when compaction is thought to occur (Figure 2).26 
Evidence regarding the proliferation of the ventricular cardiomyocytes also favours 
formation of the compact component of the wall by thickening in its own right (Figure 3), 
concomitant with the establishment of vascular supply from the aorta, rather than by 
coalescence of pre-existing trabeculations.16-18 Thus, the initial embryonic trabeculations 
have an molecular identity distinct from that of the cardiomyocytes making up the eventual 
compact ventricular walls. It is only the cardiomyocytes of the His-Purkinje system that 
retain a phenotype like the embryonic trabeculations.27 The extent to which the initial 
embryonic trabeculations retain their identity, or change their identity, remains to be fully 
established.  
What is the evidence in human supporting the notion of compaction of pre-existing 
trabeculations? 
Should compaction of pre-existing trabeculations be an important contribution to formation 
of the compact wall, we would predict that, in the adult heart, the compact wall should be 
the greatest in the hearts with the least trabeculations. To test this possibility, we assessed 
the relation of the thicknesses of the compact and trabeculated layers of the left ventricular 
wall from our published data set of almost 3000 individuals.10 This analysis shows that the 
thickness of the compacted wall is positively related to trabecular thickness, rather than 
negatively related, as would be expected if compaction is an important process (Figure 4). 
At present, therefore, the evidence from experiments and human cohort studies suggest 
that the compact wall grows by intrinsic proliferation, rather than by compaction of the pre-
existing trabecular layer. If there is a contribution exclusively due to compaction of 
embryonic trabeculations, then this contribution is likely to be negligible. Furthermore, even 
if there is failure of compaction, this may not necessarily lead to a thinned compact 
component of the wall. 
What is the evidence relating to defects of proliferation? 
If not reflecting compaction of pre-existing trabeculations, it is certainly possible that 
“noncompaction” relates to defects of proliferation.28, 29 At the time when compaction is 
thought to occur, which is around the transition from the embryonic to fetal period of 
development, the embryo weighs no more than 3 grams, with the heart itself weighing  only 
30 milligram. This is more than 4 orders of magnitude smaller than the adult arrangement.30 
If “noncompaction” is found in an infant or adult, proliferation must by necessity have 
occurred by approximately normal rates, if not normal rates. Even if we accept the 
possibility that proliferation could be pathologically reduced, it could also be argued that 
the primary pathology is hypoplasia, irrespective of the extent of trabeculation. Thus, some 
estimates of ventricular mass made based on cardiac magnetic resonance imaging indicate 
that the left ventricular mass may be slightly smaller in people with better developed 
trabeculated layers.10, 31  This would be consistent with a miniscule deficiency in 
proliferation. There is, however, considerable variation in the estimates made of the mass of 
the trabeculated component on the basis of magnetic resonance imaging.32 33 To the best of 
our knowledge, there has been no validation of how the mass of the trabeculated 
myocardial component, as estimated by echocardiography or magnetic resonance imaging, 
relates to overall left ventricular mass.  The relatively small myocardial mass as noted in 
hearts with extensive trabeculations, therefore, may simply reflect the difficulty of 
accurately distinguishing trabeculations from the lumen of the intertrabecular recesses.  
What are the phenotypic features of “noncompaction”? 
A cursory examination of the images now readily available by searching the web for 
“noncompaction” reveals marked anatomical heterogeneity. Much of the variability reflects 
the different techniques used for the purposes of diagnosis. Further problems are inherent 
in the use of various criteria for diagnosis, since these vary for those employing 
echocardiography, as they do for those using the seemingly more accurate technique of 
magnetic resonance imaging. The commonest appearance now increasingly demonstrated 
in individuals undergoing assessment using magnetic resonance imaging is that of a left 
ventricular cavity with a luminal lace-like layer of trabeculations. This lace-like layer is 
discrete from the compact components of the ventricular walls, with the trabeculations 
themselves coalescing to become the papillary muscles of the mitral valve. Within such 
images, it is also frequent to observe the innermost parts of the luminal trabecular layer 
also to be relatively compacted. This produces a trilaminar rather than a bilaminar 
configuration. In this pattern, the compact wall forms a relatively thick layer, the lace-like 
trabeculations form the middle part of the wall, and the innermost trabeculations coalesce 
to form a thin layer, with this layer continuous basally with the papillary muscles of the 
mitral valve. The bases of the left ventricular papillary muscles, however, are known to be 
trabeculated in the healthy heart.34 It is possible, therefore, that the trilaminar mural 
architecture as seen in such examples of “noncompaction” is no more than an excessive 
representation of the normal setting. But these appearances are far from uniform.  
“Noncompaction” has a multiplicity of anatomical phenotypes 
It is, perhaps, surprising that, none of the images available from autopsied hearts replicate 
the trilaminar appearance described above. The images from autopsies typically, tend to 
reveal the presence of hypertrophied trabeculations, often in presence of a fibroelastotic 
endocardial surface layer. This produces a more obvious bilaminar arrangement. Some of 
the clinical images similarly show hypertrophied trabeculations, rather than the lace-like 
configuration visible in most of the magnetic resonance images. Most cartoons alleging to 
show the appearances of the lesion, in contrast, show deep recesses extending into the 
compact component of the wall. Such features are lacking in those cases diagnosed using 
magnetic resonance imaging. The images now available in these multiple publications 
suggest that there is no one arrangement that represents the condition, but rather a 
multiplicity of phenotypes. The distribution of the excessive trabeculations, furthermore, is 
also unhelpful. Petersen and colleagues7 found a very similar spread of trabeculations in 
healthy volunteers, athletes, patients with hypertrophic cardiomyopathy, hypertensive 
heart disease, dilated cardiomyopathy, aortic stenosis, and those with “noncompaction”. 
This was subsequently confirmed by Jacquier and colleagues.4 Recent findings in large 
cohorts of healthy people now show that many individuals are positive for one criterion, or 
even several criteria, of “noncompaction” despite being asymptomatic.10 31 In one 
prospective study of 113 individuals positive for “noncompaction”, the incidence of 
pathological events did not associate with the greatest extent of trabeculations.35 Instead, it 
was ventricular dilation, and fibrosis as assessed with late gadolinium enhancement, that 
achieved prognostic value. This, of course, is as found in other cardiomyopathies. A smaller 
study in children also revealed that excessive trabeculations did not have prognostic value.36 
All of this evidence, therefore,  supports the notion that presence of excessive 
trabeculation, in themselves, is an epiphenomenon.37 
What, then, are the genetics of excessive trabeculation? 
It is established that “noncompaction” often associates with mitochondrial disorders.38, 39 
Genetic defects are identified in some two-fifths of patients, and these defects are 
distributed on 20 different genes.40 The affected genes often code for proteins that 
constitute part of the contractile apparatus, or otherwise partake in the excitation-
contraction coupling, such as the calcium handling ryanodine receptors.11, 41, 42 The same 
genes, however, are linked to cardiomyopathies in general. There is nothing, to the best of 
our knowledge, that points to the trabeculated myocardium being more affected than the 
compact myocardium. One exception in this regard may be HCN4.43, 44 The expression of the 
funny channel protein in the ventricles is known to be confined to the ventricular 
conduction system, which is itself derived from the embryonic trabeculations, but HCN4 is 
further expressed in the sinus and atrioventricular node.27, 45 Thus, the clinical presentation 
of patients with mutations in HCN4 is confounded by the malfunctioning cardiac conduction 
system, again calling into question whether the excessive trabeculations are the causative 
agent, or simply an epiphenomenon. Perhaps the best attempt causally to relate genetic 
variation to “noncompaction” was made by Luxan and colleagues.46 In their study, all 10 
carriers of mutations in the MIB1 gene of the two index families were positive for either the 
Petersen7or Jacquier4 criterion for “noncompaction”. Only 2 individuals, nonetheless, had 
heart failure. The remaining 8 carriers had benign “noncompaction, since they had normal 
left ventricular ejection fractions.47 More recently, Piccolo et al studied carriers of MIB2 
mutation and only every second carrier satisfied the currently accepted criteria for 
“noncompaction” and all carriers had benign “noncompaction”.48 As of yet, therefore, 
clinical genetics do not lend unequivocal support to the categorization of “noncompaction” 
as a distinct cardiomyopathy. Instead, some key findings can be considered in line with the 
notion of excessive trabeculation occurring as an epiphenomenon. 
Is there a difference between children and adults? 
Another of the key questions relates to whether the condition seen in children is different 
from adults. In case series of children diagnosed with “noncompaction”, the prognosis 
appears to be poor,49 with some investigators finding a high mortality in individuals with low 
ejection fractions.50 It is likely that those with more severe forms of excessive trabeculation 
present in childhood,47 perhaps explaining the more benign adult forms. Certainly, a 
survivor bias may partly explain the differences found. In neither childhood, nor in adult, 
studies of those with excessive trabeculations, however, is there convincing evidence that 
the presence or the degree of excessive trabeculation has an independent prognostic value 
after adjusting for common and known risk factors, such as left ventricular end-diastolic 
diameter or volume or ejection fraction. It remains an open question, furthermore, whether 
the extent of trabeculation in relation to the compact wall is constant from childhood to 
adulthood. In peripartum cardiomyopathy, for example, the trabeculated layer is known to 
thicken to a greater extent than the compact wall.51 
How best, then, can we describe the condition?  
Although the appearance is most frequently described as “noncompaction”, we submit that 
all our discussion shows this to be less than satisfactory. The very use of the term implies 
that there has been some degree of failure of compaction during development. As shown 
above, there is no evidence of which we are aware to show that the initial embryonic 
trabeculations contribute substantially to the compact wall by a process of compaction. 
Extensive embryonic-like trabeculations can be expected if there is failed compaction, but, 
as one of us has recently shown in fetal cases that could be diagnosed as showing 
“noncompaction”, the excessive trabeculations themselves do not have the embryonic 
identity of the initial trabecular layer.52 An alternative term, used as the condition began to 
achieve prominence, was “spongy myocardium”. It is certainly the case that the lace-like 
configuration seen in many individuals has a sponge-like appearance, but the term is 
confounded by the inference that the “sponginess” is reminiscent of hearts found in cold-
blooded, or ectothermic, species. This association has been shown to be false12. Despite the 
frequent presumption that the trabecular layer is formed at the expense of the compact 
layer in “noncompaction”, this is not the case. “Spongy” myocardium, therefore, is also less 
than ideal. “Hypertrabeculation” is another alternative that is again far from ideal. Does the 
prefix imply that there are too many trabeculations, or that the existing trabeculations are 
hypertrophied? And, if we are to judge the number of trabeculations, what is our point of 
reference? The term that, perhaps, best expresses the anatomical configuration 
underscoring the criteria proposed by Petersen and colleagues7 is excessive trabeculation. 
The extent of the trabeculations is certainly greater than that seen within the left ventricles 
of most normal individuals. Having described excessive trabeculation, it is then possible to 
explain whether the individual trabeculations are lace-like, or additionally hypertrophied 
and thickened, thus accounting for the variability to be found within published images.  
How excessive are the trabeculations?  
The burning current question is whether the excessive nature of the trabeculations 
represents an abnormality in itself, or is no more than an epiphenomenon. There is now 
much evidence accruing to favour the second alternative.39 The extensive investigation of 
the individuals collected together in the multi-ethnic study of atherosclerosis shows that 
there is a fairly normal distribution of the extent of trabeculation, forming a bell-shaped 
curve with a degree of rightward skewing (Figure 5). Those individuals making up the 
rightward end of the curve satisfy the accepted criteria established for diagnosis of 
“noncompaction” when using magnetic resonance imaging. Many individuals with excessive 
trabeculations, however, have none of the anticipated symptoms for “noncompaction”. 
One-third of the cohort of patients with dilated cardiomyopathy studied by Amzulescu and 
colleagues, for example, also fulfilled these criteria.53 In commentating on their publication, 
one of us emphasised that “it seems that there is no convincing evidence to suggest that the 
degree of trabeculations has incremental prognostic value in asymptomatic low-risk 
populations and in dilated cardiomyopathy”.54 Stöllberger and colleagues, furthermore, 
showed that the presence of excessive trabeculations did not predict clinical outcomes in 
adults.55 Further corroboration of these notions is now provided by the recent publications 
based, on the one hand, on  a large cohort of healthy people, and on the other hand a 
prospective study of 113 individuals positive for “noncompaction”.31, 35 
 
How, then, should we assess individuals with excessive trabeculation? 
There is significant controversy regarding the appropriate diagnostic criteria for 
“noncompaction”. The current imaging techniques for the diagnosis have recently been 
reviewed, and controversies outlined.56 Some authors rely on a ratio of compacted to 
trabeculated myocardium of greater than 2, or a trabecular mass of greater than 20% of 
total mass.4 The estimation of ventricular mass made by Jacquier et al, however, is greatly 
exaggerated, since they included the intertrabecular lumens as part of the trabeculated 
mass. Individuals show a wide spectrum in the extent and thickness of trabeculations. Many 
of these individuals have no evidence of heart disease, suggesting a potential diagnosis of 
“noncompaction” would be erroneous. We have shown in our discussion above that 
“noncompaction”, as a term, probably does not reflect the underlying disease process. The 
use of the word “cardiomyopathy”, furthermore, is problematic in the presence of a 
normally functioning heart. Some have suggested that, in addition to the presence of 
excessive trabeculations, various additional indices, such as mural thickness57 and ejection 
fraction, should be considered. The presence of a reduced ejection fraction, in the absence 
of another cause, certainly reflects a cardiomyopathic process, and may be an important 
marker for a disease process (Figure 6). Recently, Andreini and colleagues showed that 
dilation of the left ventricle, along with fibrosis as revealed by late gadolinium 
enhancement, do have prognostic value.35 This does suggest that a reduced ejection 
fraction, fibrosis in itself, or a dilated left ventricle, should be a prerequisite for diagnosing a 
clinically important condition. These parameters, nonetheless, are the hallmarks of 
cardiomyopathy in general. In this regard, Arbustini and her associates have suggested that, 
in many instances, “noncompaction” can adequately be described simply in terms of dilated, 
hypertrophic, restrictive cardiomyopathy, or arrhythmogenic right ventricular 
cardiomyopathy.39 
Is there a specific difference between “noncompaction” and dilated cardiomyopathy in 
the setting of excessive trabeculations? 
Whether or not “noncompaction” represents a distinct cardiomyopathy is also 
controversial.41 A thin compacted layer is seen by some as a prerequisite for the diagnosis.1, 
39, 41 In another study with age and sex matched adults, a maximal compacted thickness of 
less than 8 mm was proposed as a specific marker that would allow the differentiation of 
the pathological variant of excessive trabeculation, and thus prevent over-diagnosis.57 It is 
certainly possible that presence of excessive trabeculations, in some individuals, may simply 
be a marker for an unusually thin compact component of the ventricular wall, in other 
words an associated developmental abnormality, with more benign forms having a normal 
ejection fraction and wall thickness.47 In individuals with excessive trabeculations, it is those 
with lower ejection fraction, a higher end-diastolic volume, and heart failure symptoms who 
have increased mortality.58 
We must ask, therefore, whether the presence of of a normal ejection fraction in the setting 
of excessive trabeculation excludes a disease process? Patients with excessive trabeculation 
and a normal ejection fraction do not appear to be at an increased risk of arrhythmias and 
embolic stroke.10 Of the dataset of more than 3000 asymptomatic participants making up 
the MESA cohort, the quintile with the greatest ratio between the thicknesses of the 
trabeculated and compact layers did not have greater risk for either arrhythmia or stroke.10 
Excessive trabeculations, nonetheless, are known to be associated with several genetic 
abnormalities,39, 59, 60 including abnormalities in cardiomyocyte proteins, NOTCH signalling 
pathways,47 and calcium handling.42, 61 These findings raise the possibility of a unifying 
developmental abnormality, which sometimes produces both an abnormal compacted layer 
and excessive trabeculations. The architecture of the trabecular layer, however, may also be 
relevant. Some individuals have the lace-like appearance, with thin trabeculations, while 
others have much thicker individual trabeculations. It remains uncertain as to whether these 
individuals have different clinical phenotypes and outcomes.  
Case series have shown a high risk of ventricular arrhythmias, especially in symptomatic 
individuals, although more recent studies indicate a more benign outlook.47 The potential 
mechanism for arrhythmias in the setting of excessive trabeculation is currently unknown.47 
Some individuals with ventricular arrhythmias in one study had decreased fractional 
shortening, and increased left ventricular end-diastolic dimensions, although those without 
arrhythmias had even lower measures.62  Worsening left ventricular ejection fraction is 
established as an important predictor for ventricular arrhythmias and mortality in children.50 
Age at presentation, as well as the extent of the trabeculations, appears to be a major 
determinant of left ventricular ejection fraction.63 Ejection fraction,63, 64 functional capacity63 
or history of heart failure, 65 sustained ventricular tachycardia65 and an enlarged left 
atrium65 have all been shown to predict mortality.  
We suggest, therefore, that excessive trabeculation can occur in individuals with an 
excellent outlook, as an overlap syndrome with dilated cardiomyopathy secondary to a 
cardiomyocyte disease or related to thinner ventricular wall,66 or can appear secondary to a 
concurrent developmental abnormality (Figure 7).  As already discussed, Arbustini and 
colleagues have proposed the sub-grouping of the finding of excessive trabeculation. They 
argued that individuals could be asymptomatic or symptomatic, with the symptoms 
reflecting associated cardiomyopathies, congenital malformations, being part of a 
syndrome, or acquired in relation to exercise or pregnancy.39 The suggested approach poses 
many questions, such as the prevalence, incidence, diagnostic criteria, prognosis and 
management of each of these suggested groupings, thus providing rich areas for future 
research. 
Conclusions 
There is growing evidence to indicate the lack of any connection between the mere 
presence of excessive ventricular trabeculation and mortality, the risk of arrhythmias, or 
stroke. Specifically, there is no convincing evidence that the extent of ventricular 
trabeculations has incremental prognostic value in asymptomatic individuals, those with a 
normal ejection fraction or even in those with dilated cardiomyopathy. “Noncompaction”, 
as currently defined, is neither "arrested development", nor failure of the compaction of 
pre-existing trabeculations, nor a recapitulation of an evolutionary arrangement found in 
cold-blooded animals. Indeed, the condition, if it is one, is no more than excessive 
trabeculation! We conclude that compaction is not an important process for the formation 
of the compact wall, and that defining “noncompaction” without reference to left 
ventricular ejection fraction is unhelpful. We suggest that many individuals currently 
diagnosed as having “noncompaction” are fit and well, with an excellent prognosis. More 
research is needed to demonstrate if there is a clear phenotypic, pathophysiological, and 
prognostic difference between individuals with low ejection fraction with and without 
excessive trabeculations. Until then, it is questionable whether the entity, as currently 
identified, can be considered either as a separate disease, or as a useful diagnosis. We 
suggest that the term “noncompaction cardiomyopathy” should be abandoned, being 
replaced with a description of the trabeculations, along with risk factors such as ejection 
fraction (Figure 6). 
Figures 
Figure 1. Development of the compact and trabecular layers in humans 
The images show “four chamber” sections through the heart of human embryos, from the 
sixth (Carnegie stage (CS) 12) through the seventh week (CS 17) of intrauterine 
development. They show the increasing thickness of the compact component of the wall 
after CS 15, with the trabeculations beginning to compact to form the papillary muscles of 
the mitral valve. There is no evidence, however, to show that compaction of the pre-existing 
trabecular layer forms the solid layer.  
 
Figure 2. Lineage tracing of the embryonically formed trabeculations 
Showing embryonically formed trabeculations, traced by their expression of Cx40 from 12.5, 
14.5 and 16.5 days into development, have very little if any contribution to the compact 
wall. From Miquerol et al 201026 reproduced with permission. 
 
Figure 3 Development of the compact and trabecular layers in mice 
The images, again in four chamber orientation, are from developing mouse hearts during 
the eleventh, twelfth, thirteenth, and fifteenth days of embryonic (E) development. The 
changes in thickness of the trabecular and compact layers parallel the changes seen in the 
developing human heart (Figure 1). As in the human heart, the trabeculations compact to 
form the papillary muscles (E14.5), but not the compact part of the ventricular wall. 
Figure 4. Relationship between thickness of trabecular and compacted layers of 
myocardium in MESA cohort 
In these patients with a normal ejection fraction, trabecular thickness and compacted wall 
thickness correlate suggesting that compaction is not an important process in formation of 
the compact ventricular wall.  
 
Figure 5. Distortion of the frequency distribution of the ratio of trabeculation to 
compacted wall thickness by logarithmic transformation. 
Showing the skewed distribution of the frequency of the ratio of trabeculation to 
compacted wall thickness and normal distribution after logarithmic transformation. 
 
Figure 6. Proposed algorithm for excessive trabeculations management and risk 
assessment (adapted from Aung et al.67) 
A possible algorithm for the assessment of individuals with excessive trabeculation, which 
proposes that some individuals may not require long-term follow-up. Prognostic 
arrhythmias include non-sustained ventricular tachycardia (NSVT). LVEF, left ventricular 
ejection fraction; FH DCM/NCC, family history of dilated cardiomyopathy or non-compaction 
cardiomyopathy. 
 
Figure 7. Possible categories with excessive trabeculations.  
Excessive trabeculations (defined as Petersen positive criteria7) with preserved ejection 
fraction (ETpEF). Excessive trabeculations with reduce ejection fraction (ETrEF) and dilated 
cardiomyopathy (DCM). Shown is a potential overlap syndrome with ETrEF and DCM and a 
distinct group (NCC) related to a developmental disorder as defined by Jenni and colleagues, 
where the diagnostic criteria include a thin compact layer.1 
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